Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free SCSC Stock Alerts

ScanSource (SCSC) Financials

ScanSource logo
$58.48 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern
Compare
Annual Income Statements for ScanSource

Annual Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 64 69 33 58 -193 11 89 90 77 72 79
Consolidated Net Income / (Loss)		 64 69 33 58 -193 11 89 90 77 72 79
Net Income / (Loss) Continuing Operations		 64 69 35 65 -79 45 89 88 77 72 79
Total Pre-Tax Income 		96 101 63 84 -72 58 119 122 100 94 104
Total Operating Income		 97 88 69 95 -65 61 122 136 90 85 99
Total Gross Profit		 355 384 369 393 356 351 427 449 399 409 437
Total Revenue		 3,540 3,568 3,165 3,250 3,048 3,151 3,530 3,788 3,260 3,041 3,226
Operating Revenue		 3,540 3,568 3,165 3,250 3,048 3,151 3,530 3,788 3,260 3,041 3,226
Total Cost of Revenue		 3,185 3,185 2,795 2,857 2,692 2,800 3,103 3,338 2,861 2,632 2,789
Operating Cost of Revenue		 3,185 3,185 2,795 2,857 2,692 2,800 3,103 3,338 2,861 2,632 2,789
Total Operating Expenses		 259 295 300 298 421 289 304 313 309 323 339
Selling, General & Admin Expense		 240 265 232 244 260 247 275 286 277 287 313
Depreciation Expense		 7.33 9.40 12 12 13 13 11 11 11 10 5.99
Amortization Expense		 9.80 16 19 18 20 19 18 17 16 19 17
Restructuring Charge		 - - - 8.65 0.60 9.26 0.00 0.00 4.36 5.38 1.77
Other Special Charges / (Income)		 1.29 5.21 37 15 6.94 0.52 - 0.00 0.00 1.90 1.07
Total Other Income / (Expense), net		 -0.87 13 -5.96 -11 -6.81 -3.95 -3.54 -14 9.52 9.20 5.12
Interest Expense		 2.12 3.22 9.12 13 12 6.93 6.52 20 13 8.01 6.59
Interest & Investment Income		 3.45 5.33 3.71 1.82 5.83 3.10 4.33 7.41 9.38 11 12
Other Income / (Expense), net		 -2.19 11 -0.55 0.25 -0.41 -0.12 -1.35 -1.66 13 5.96 -0.56
Income Tax Expense		 32 32 28 19 7.45 12 30 34 23 23 25
Basic Earnings per Share		 $2.40 $2.74 $1.30 $2.25 ($7.59) $0.42 $3.48 $3.57 $3.10 $3.05 $3.69
Weighted Average Basic Shares Outstanding		 26.47M 25.32M 25.52M 25.64M 25.38M 25.42M 25.50M 25.14M 24.87M 23.44M 21.38M
Diluted Earnings per Share		 $2.38 $2.71 $1.29 $2.24 ($7.59) $0.42 $3.45 $3.54 $3.06 $3.00 $3.64
Weighted Average Diluted Shares Outstanding		 26.69M 25.52M 25.62M 25.73M 25.38M 25.52M 25.76M 25.36M 25.22M 23.84M 21.69M
Weighted Average Basic & Diluted Shares Outstanding		 26.50M 25.30M 25.50M 25.24M 25.36M 25.50M 25.19M 24.84M 24.03M 21.88M 20.14M

Quarterly Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 33 13 16 17 17 17 20 20 16 17 26
Consolidated Net Income / (Loss)		 33 13 16 17 17 17 20 20 16 17 26
Net Income / (Loss) Continuing Operations		 33 13 16 17 17 17 20 20 16 17 26
Total Pre-Tax Income 		40 18 23 23 20 24 27 27 19 24 33
Total Operating Income		 27 18 22 18 18 22 27 26 18 23 32
Total Gross Profit		 101 94 97 102 102 100 105 107 103 107 120
Total Revenue		 885 753 746 776 747 705 813 740 767 767 953
Operating Revenue		 885 753 746 776 747 705 813 740 767 767 953
Total Cost of Revenue		 784 658 649 674 646 605 708 632 664 660 833
Operating Cost of Revenue		 784 658 649 674 646 605 708 632 664 660 833
Total Operating Expenses		 74 77 75 84 83 78 78 82 85 84 88
Selling, General & Admin Expense		 67 67 68 72 74 70 72 75 78 78 82
Depreciation Expense		 2.96 2.69 2.77 2.86 2.90 2.32 1.93 1.58 1.43 1.50 1.48
Amortization Expense		 4.04 3.75 3.74 4.36 5.00 4.94 4.93 4.40 4.29 4.00 4.03
Restructuring Charge		 0.00 3.92 - 5.07 0.31 0.00 - 0.00 0.00 0.00 1.77
Other Special Charges / (Income)		 0.00 0.00 - 0.00 1.14 0.90 - 0.31 1.21 0.44 -0.89
Total Other Income / (Expense), net		 13 0.41 0.82 5.33 1.27 1.89 0.71 1.09 1.55 0.93 1.54
Interest Expense		 3.36 2.00 2.09 2.11 1.97 1.84 2.10 1.91 1.95 1.30 1.43
Interest & Investment Income		 2.12 2.65 3.29 2.66 2.69 2.84 3.05 3.18 3.36 2.45 3.27
Other Income / (Expense), net		 14 -0.24 -0.38 4.78 0.54 0.88 -0.25 -0.17 0.14 -0.22 -0.30
Income Tax Expense		 7.32 5.15 6.60 5.99 2.66 6.80 7.41 7.12 2.93 7.17 7.66
Basic Earnings per Share		 $1.31 $0.51 $0.66 $0.70 $0.72 $0.75 $0.88 $0.90 $0.75 $0.79 $1.25
Weighted Average Basic Shares Outstanding		 25.04M 25.03M 24.87M 24.15M 23.81M 23.28M 23.44M 22.02M 21.87M 21.31M 21.38M
Diluted Earnings per Share		 $1.29 $0.50 $0.66 $0.69 $0.70 $0.74 $0.87 $0.89 $0.75 $0.78 $1.22
Weighted Average Diluted Shares Outstanding		 25.33M 25.44M 25.22M 24.65M 24.22M 23.60M 23.84M 22.41M 22.11M 21.58M 21.69M
Weighted Average Basic & Diluted Shares Outstanding		 25.17M 24.71M 24.03M 0.00 23.46M 22.60M 21.88M 21.94M 21.48M 20.32M 20.14M

Annual Cash Flow Statements for ScanSource

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 -60 -4.87 -35 -1.71 11 28 -25 -1.81 149 -59 -38
Net Cash From Operating Activities		 52 95 25 16 182 117 -124 -36 372 112 123
Net Cash From Continuing Operating Activities		 52 95 31 16 182 117 -124 -36 372 112 123
Net Income / (Loss) Continuing Operations		 64 69 35 65 -79 45 89 88 77 72 79
Consolidated Net Income / (Loss)		 64 69 33 58 -193 11 89 90 77 72 79
Depreciation Expense		 17 25 34 34 35 34 30 29 28 30 24
Amortization Expense		 0.30 0.29 0.33 0.35 0.42 0.42 0.42 0.58 0.39 0.39 0.62
Non-Cash Adjustments To Reconcile Net Income		 15 15 9.44 -2.43 125 5.96 13 14 3.80 19 20
Changes in Operating Assets and Liabilities, net		 -43 -15 -48 -80 101 31 -257 -167 262 -9.28 -0.06
Net Cash From Investing Activities		 -74 -96 -152 -38 -55 32 -3.72 -8.26 9.05 -62 -28
Net Cash From Continuing Investing Activities		 -74 -96 -151 -38 -55 32 -3.72 -8.26 9.05 -62 -28
Purchase of Property, Plant & Equipment		 -12 -8.85 -7.00 -5.80 -6.39 -2.36 -6.85 -9.98 -8.56 -8.29 -9.29
Acquisitions		 -61 -87 -144 -32 -49 - - 0.00 0.00 -57 -18
Divestitures		 - - - 0.00 0.00 34 3.13 1.72 18 2.57 0.00
Net Cash From Financing Activities		 -36 -3.51 101 31 -153 -119 108 40 -228 -111 -134
Net Cash From Continuing Financing Activities		 -36 -3.51 101 31 -153 -119 108 40 -228 -111 -134
Repayment of Debt		 -1,308 -1,794 -2,150 -2,134 -2,196 -1,957 -2,040 -2,442 -1,447 -61 -430
Repurchase of Common Equity		 -100 -21 0.00 -9.48 -6.08 0.00 -18 -16 -43 -107 -98
Issuance of Debt		 1,377 1,813 2,301 2,211 2,086 1,882 2,166 2,499 1,260 52 393
Other Financing Activities, net		 -4.51 -1.94 -50 -36 -36 -43 -0.45 -1.55 1.94 4.62 0.55
Effect of Exchange Rate Changes		 -2.60 - - 0.56 -3.64 3.71 -4.76 2.69 -3.64 1.64 1.07
Cash Interest Paid		 1.71 2.83 8.61 13 12 6.41 6.07 19 13 7.57 6.10
Cash Income Taxes Paid		 34 31 36 31 17 12 29 29 27 28 29

Quarterly Cash Flow Statements for ScanSource

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 2.34 114 26 -40 -35 36 -20 -1.23 -41 37 -32
Net Cash From Operating Activities		 63 160 55 45 -6.19 66 7.65 23 31 71 -2.27
Net Cash From Continuing Operating Activities		 63 160 55 45 -6.19 66 7.65 23 31 71 -2.27
Net Income / (Loss) Continuing Operations		 33 13 16 17 17 17 20 20 16 17 26
Consolidated Net Income / (Loss)		 33 13 16 17 17 17 20 20 16 17 26
Depreciation Expense		 7.26 6.74 6.79 7.47 8.13 7.49 7.10 6.20 5.94 5.71 5.78
Amortization Expense		 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.34 0.09 0.09
Non-Cash Adjustments To Reconcile Net Income		 -12 3.80 4.67 4.17 7.29 4.69 3.34 4.82 7.33 3.77 4.16
Changes in Operating Assets and Liabilities, net		 35 137 27 16 -39 36 -23 -7.78 0.75 45 -38
Net Cash From Investing Activities		 15 -2.42 -1.65 -59 0.77 -1.42 -2.52 -2.40 -20 -2.26 -2.52
Net Cash From Continuing Investing Activities		 15 -2.42 -1.65 -59 0.77 -1.42 -2.52 -2.40 -20 -2.26 -2.52
Purchase of Property, Plant & Equipment		 -2.55 -2.42 -1.27 -2.38 -1.97 -1.42 -2.52 -2.40 -1.98 -2.40 -2.52
Net Cash From Financing Activities		 -78 -43 -24 -27 -26 -31 -27 -23 -50 -34 -27
Net Cash From Continuing Financing Activities		 -78 -43 -24 -27 -26 -31 -27 -23 -50 -34 -27
Repayment of Debt		 -626 -131 -19 -9.06 -22 -14 -16 -52 -225 -48 -105
Repurchase of Common Equity		 -1.25 -20 -22 -28 -24 -29 -25 -21 -17 -33 -27
Issuance of Debt		 546 108 17 8.38 18 12 14 49 193 48 104
Other Financing Activities, net		 3.16 0.18 0.11 2.18 2.51 0.00 -0.07 0.84 0.00 -0.22 -0.07
Effect of Exchange Rate Changes		 1.50 -1.03 -2.86 0.61 -3.38 2.19 2.22 0.90 -1.65 1.50 0.32

Annual Balance Sheets for ScanSource

This table presents ScanSource's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 1,491 1,718 1,945 2,067 1,692 1,672 1,937 2,068 1,779 1,786 1,932
Total Current Assets		 1,229 1,281 1,362 1,477 1,203 1,220 1,524 1,657 1,405 1,370 1,508
Cash & Equivalents		 61 56 26 19 29 63 38 36 185 126 88
Accounts Receivable		 560 637 646 523 443 569 729 753 582 636 770
Inventories, net		 559 531 596 554 455 470 615 758 513 484 522
Prepaid Expenses		 49 56 95 84 95 118 142 110 125 122 117
Current Deferred & Refundable Income Taxes		 - - - - - - - - - 2.82 11
Plant, Property, & Equipment, net		 52 57 73 0.00 0.00 0.00 0.00 0.00 34 31 35
Total Noncurrent Assets		 210 381 510 590 489 452 414 411 341 384 390
Goodwill		 93 201 298 311 214 219 214 217 206 231 245
Intangible Assets		 51 102 137 121 122 105 84 68 38 63 64
Noncurrent Deferred & Refundable Income Taxes		 29 29 22 15 25 22 16 18 20 19 11
Other Noncurrent Operating Assets		 37 49 53 113 128 106 99 108 77 71 70
Total Liabilities & Shareholders' Equity		 1,491 1,718 1,945 2,067 1,692 1,672 1,937 2,068 1,779 1,786 1,932
Total Liabilities		 717 881 1,079 1,153 1,014 940 1,131 1,163 855 879 1,022
Total Current Liabilities		 585 656 710 701 719 733 814 787 669 683 859
Short-Term Debt		 12 31 44 42 54 7.84 12 6.92 7.86 9.18 19
Accounts Payable		 471 513 563 488 454 635 714 691 588 599 753
Current Deferred & Payable Income Tax Liabilities		 3.06 7.73 13 3.96 5.89 2.50 0.03 9.88 7.90 3.93 0.47
Other Current Liabilities		 99 105 91 65 77 88 88 79 66 71 87
Total Noncurrent Liabilities		 132 225 369 452 295 208 317 376 185 196 162
Long-Term Debt		 77 97 249 323 211 135 260 323 136 128 99
Other Noncurrent Operating Liabilities		 52 126 118 97 80 68 54 49 49 68 64
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 774 837 866 914 678 731 807 905 924 906 911
Total Preferred & Common Equity		 774 837 866 914 678 731 807 905 924 906 911
Preferred Stock		 - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 774 837 866 914 678 731 807 905 924 906 911
Common Stock		 67 61 68 64 64 71 64 58 26 0.00 0.00
Retained Earnings		 780 849 882 940 747 758 847 937 1,014 1,021 1,018
Accumulated Other Comprehensive Income / (Loss)		 -73 -73 -84 -90 -133 -98 -105 -90 -116 -114 -107

Quarterly Balance Sheets for ScanSource

This table presents ScanSource's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2022 3/31/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 2,131 1,980 1,899 1,781 1,783 1,787 1,703 1,725 1,717 1,742 1,806
Total Current Assets		 1,719 1,578 1,507 1,405 1,416 1,352 1,284 1,310 1,307 1,303 1,372
Cash & Equivalents		 66 37 43 45 159 145 111 146 125 83 120
Accounts Receivable		 780 684 692 663 590 567 549 563 557 605 628
Inventories, net		 762 753 656 575 529 504 492 476 505 490 487
Prepaid Expenses		 111 103 117 122 138 136 132 125 120 113 126
Current Deferred & Refundable Income Taxes		 - - - - - - - - - 11 10
Plant, Property, & Equipment, net		 0.00 36 0.00 0.00 36 33 30 30 32 32 34
Total Noncurrent Assets		 411 366 391 376 331 401 389 385 377 406 400
Goodwill		 214 215 215 208 208 233 228 229 231 244 245
Intangible Assets		 76 72 64 45 42 78 73 68 59 72 68
Noncurrent Deferred & Refundable Income Taxes		 15 14 16 19 19 17 18 18 17 14 16
Other Noncurrent Operating Assets		 106 65 96 103 63 73 70 70 71 76 71
Total Liabilities & Shareholders' Equity		 2,131 1,980 1,899 1,781 1,783 1,787 1,703 1,725 1,717 1,742 1,806
Total Liabilities		 1,268 1,101 983 827 839 866 802 823 803 831 899
Total Current Liabilities		 837 744 701 611 643 666 610 632 606 664 737
Short-Term Debt		 5.04 5.98 8.21 7.86 7.86 12 9.90 9.60 9.65 19 19
Accounts Payable		 749 657 618 541 556 579 520 541 530 577 647
Current Deferred & Payable Income Tax Liabilities		 6.05 4.44 8.11 3.65 4.79 6.38 8.33 13 3.56 0.27 0.28
Other Current Liabilities		 77 77 67 58 75 69 71 68 63 68 71
Total Noncurrent Liabilities		 431 357 282 217 196 200 192 192 197 167 163
Long-Term Debt		 378 305 240 161 138 134 132 130 126 100 99
Other Noncurrent Operating Liabilities		 51 49 39 56 58 66 60 61 71 67 64
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 862 879 915 954 944 921 901 902 914 911 906
Total Preferred & Common Equity		 862 879 915 954 944 921 901 902 914 911 906
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 862 879 915 954 944 921 901 902 914 911 906
Common Stock		 68 60 60 64 46 2.98 0.00 0.00 0.00 0.00 0.00
Retained Earnings		 897 918 952 985 998 1,031 1,032 1,023 1,025 1,027 1,015
Accumulated Other Comprehensive Income / (Loss)		 -103 -99 -96 -95 -100 -113 -131 -122 -111 -116 -109

Annual Metrics And Ratios for ScanSource

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - - 20,324,529.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 20,324,529.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 3.88
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 9.99% 0.79% -11.31% 2.69% -6.22% 3.38% 12.03% 7.30% -13.94% -6.72% 6.09%
EBITDA Growth		 0.70% 11.15% -17.14% 24.89% -122.97% 421.57% 58.58% 8.14% -19.29% -7.69% 0.47%
EBIT Growth		 -4.42% 4.96% -31.11% 38.74% -168.83% 193.86% 96.87% 11.10% -22.90% -11.91% 7.58%
NOPAT Growth		 -3.36% -6.22% -35.54% 89.31% -161.90% 206.66% 88.33% 7.54% -29.04% -7.37% 16.11%
Net Income Growth		 -2.75% 8.84% -52.12% 73.73% -434.49% 105.60% 722.58% 1.14% -14.20% -7.15% 10.24%
EPS Growth		 4.85% 13.87% -52.40% 73.64% -438.84% 105.53% 721.43% 2.61% -13.56% -1.96% 21.33%
Operating Cash Flow Growth		 -30.87% 81.72% -73.85% -35.37% 1,035.44% -35.85% -206.50% 71.24% 1,139.02% -69.77% 9.60%
Free Cash Flow Firm Growth		 -58.51% -48.69% -292.19% 174.51% 17.60% -40.01% -240.26% 55.33% 731.87% -92.30% 78.00%
Invested Capital Growth		 13.60% 13.41% 24.67% -5.71% -19.46% -5.69% 28.10% 15.32% -26.37% 3.95% 2.41%
Revenue Q/Q Growth		 0.59% 1.13% -16.05% 0.78% 10.87% 7.37% 3.20% -0.40% -5.81% 2.25% 4.54%
EBITDA Q/Q Growth		 -5.16% 4.66% -0.64% 3.06% -127.79% 332.09% 2.03% -0.16% -4.28% 4.60% 3.00%
EBIT Q/Q Growth		 -6.64% 4.05% -1.01% 4.42% -188.87% 181.14% 2.89% 0.15% -4.99% 5.86% 5.25%
NOPAT Q/Q Growth		 -4.95% 8.26% -11.92% 12.45% -180.86% 192.09% -0.06% -1.05% -6.15% 6.68% 6.91%
Net Income Q/Q Growth		 -5.25% 9.56% -20.56% 2.11% -632.38% 104.69% -4.07% -1.25% -3.40% 5.91% 7.54%
EPS Q/Q Growth		 -2.86% 9.27% -20.37% 2.28% -634.51% 104.63% -4.43% -0.56% -3.16% 7.53% 10.64%
Operating Cash Flow Q/Q Growth		 -28.18% -15.31% 448.56% 147.06% 22.45% -9.74% -893.38% 63.94% 23.21% -29.54% -7.45%
Free Cash Flow Firm Q/Q Growth		 -119.98% -76.21% 19.25% 393.62% 55.20% -71.04% -942.69% 43.81% 30.38% -69.12% -13.27%
Invested Capital Q/Q Growth		 -0.96% 1.94% -2.76% -16.37% -29.99% -3.39% 10.07% 4.03% -5.16% 2.51% 3.92%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 10.04% 10.75% 11.67% 12.09% 11.67% 11.13% 12.08% 11.86% 12.24% 13.44% 13.56%
EBITDA Margin		 3.17% 3.49% 3.26% 3.97% -0.97% 3.02% 4.28% 4.31% 4.05% 4.00% 3.79%
Operating Margin		 2.74% 2.47% 2.18% 2.92% -2.13% 1.95% 3.46% 3.59% 2.77% 2.80% 3.06%
EBIT Margin		 2.67% 2.79% 2.16% 2.92% -2.15% 1.95% 3.42% 3.54% 3.17% 3.00% 3.04%
Profit (Net Income) Margin		 1.80% 1.94% 1.05% 1.77% -6.32% 0.34% 2.52% 2.37% 2.36% 2.35% 2.44%
Tax Burden Percent		 66.26% 68.23% 52.58% 68.87% 268.41% 18.76% 74.86% 73.70% 77.18% 75.80% 76.03%
Interest Burden Percent		 101.40% 102.13% 92.10% 88.06% 109.79% 93.76% 98.19% 90.78% 96.47% 103.55% 105.78%
Effective Tax Rate		 33.74% 31.77% 43.76% 22.45% 0.00% 21.11% 25.23% 27.70% 22.82% 24.20% 23.97%
Return on Invested Capital (ROIC)		 8.52% 7.04% 3.80% 6.67% -4.71% 5.80% 9.87% 8.78% 6.70% 7.17% 8.07%
ROIC Less NNEP Spread (ROIC-NNEP)		 10.02% 25.32% 0.46% -0.86% -92.11% -22.89% 8.24% 5.58% 12.52% -39.15% 27.36%
Return on Net Nonoperating Assets (RNNOA)		 -0.48% 1.55% 0.09% -0.20% -19.48% -4.27% 1.68% 1.72% 1.73% 0.64% 0.61%
Return on Equity (ROE)		 8.04% 8.59% 3.89% 6.47% -24.20% 1.53% 11.55% 10.49% 8.42% 7.82% 8.68%
Cash Return on Invested Capital (CROIC)		 -4.22% -5.53% -18.16% 12.55% 16.84% 11.66% -14.77% -5.46% 37.07% 3.30% 5.69%
Operating Return on Assets (OROA)		 6.38% 6.19% 3.74% 4.73% -3.48% 3.65% 6.69% 6.70% 5.38% 5.11% 5.28%
Return on Assets (ROA)		 4.29% 4.32% 1.81% 2.87% -10.25% 0.64% 4.92% 4.48% 4.01% 4.01% 4.24%
Return on Common Equity (ROCE)		 8.04% 8.59% 3.89% 6.47% -24.20% 1.53% 11.55% 10.49% 8.42% 7.82% 8.68%
Return on Equity Simple (ROE_SIMPLE)		 8.21% 8.27% 3.83% 6.30% -28.40% 1.48% 11.01% 9.92% 8.34% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 64 60 39 73 -45 49 91 98 70 65 75
NOPAT Margin		 1.81% 1.69% 1.23% 2.26% -1.49% 1.54% 2.59% 2.59% 2.14% 2.12% 2.32%
Net Nonoperating Expense Percent (NNEP)		 -1.50% -18.28% 3.34% 7.53% 87.40% 28.69% 1.63% 3.20% -5.82% 46.32% -19.29%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - 6.19% 7.29%
Cost of Revenue to Revenue		 89.96% 89.25% 88.33% 87.91% 88.33% 88.87% 87.92% 88.14% 87.76% 86.56% 86.44%
SG&A Expenses to Revenue		 6.78% 7.43% 7.34% 7.52% 8.52% 7.85% 7.80% 7.54% 8.51% 9.44% 9.71%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 7.30% 8.28% 9.49% 9.17% 13.80% 9.18% 8.62% 8.27% 9.47% 10.64% 10.50%
Earnings before Interest and Taxes (EBIT)		 95 99 68 95 -65 61 121 134 103 91 98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 112 125 103 129 -30 95 151 163 132 122 122
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.23 1.22 1.19 0.92 0.90 0.98 0.97 0.81 1.18 1.04 1.16
Price to Tangible Book Value (P/TBV)		 1.51 1.91 2.39 1.74 1.78 1.76 1.55 1.19 1.61 1.54 1.76
Price to Revenue (P/Rev)		 0.27 0.29 0.33 0.26 0.20 0.23 0.22 0.19 0.34 0.31 0.33
Price to Earnings (P/E)		 14.97 14.73 31.08 14.53 0.00 66.36 8.85 8.20 14.21 13.20 13.42
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 6.68% 6.79% 3.22% 6.88% 0.00% 1.51% 11.30% 12.20% 7.04% 7.57% 7.45%
Enterprise Value to Invested Capital (EV/IC)		 1.22 1.20 1.14 1.11 0.98 0.98 0.98 0.86 1.19 1.04 1.16
Enterprise Value to Revenue (EV/Rev)		 0.28 0.31 0.41 0.36 0.28 0.25 0.29 0.27 0.32 0.31 0.34
Enterprise Value to EBITDA (EV/EBITDA)		 8.73 8.76 12.56 9.18 0.00 8.36 6.74 6.30 7.99 7.85 8.89
Enterprise Value to EBIT (EV/EBIT)		 10.34 10.99 18.95 12.46 0.00 12.98 8.43 7.67 10.18 10.49 11.09
Enterprise Value to NOPAT (EV/NOPAT)		 15.26 18.14 33.43 16.11 0.00 16.43 11.15 10.48 15.11 14.80 14.51
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.76 11.51 52.30 73.82 4.65 6.82 0.00 0.00 2.83 8.51 8.83
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 8.57 5.21 8.18 0.00 0.00 2.73 32.18 20.57
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.11 0.15 0.34 0.40 0.39 0.20 0.34 0.36 0.16 0.15 0.13
Long-Term Debt to Equity		 0.10 0.12 0.29 0.35 0.31 0.19 0.32 0.36 0.15 0.14 0.11
Financial Leverage		 -0.05 0.06 0.20 0.24 0.21 0.19 0.20 0.31 0.14 -0.02 0.02
Leverage Ratio		 1.87 1.99 2.15 2.25 2.36 2.39 2.35 2.34 2.10 1.95 2.05
Compound Leverage Factor		 1.90 2.03 1.98 1.98 2.59 2.24 2.30 2.12 2.03 2.02 2.16
Debt to Total Capital		 10.25% 13.26% 25.23% 28.58% 28.10% 16.37% 25.16% 26.71% 13.48% 13.17% 11.42%
Short-Term Debt to Total Capital		 1.34% 3.18% 3.76% 3.32% 5.74% 0.90% 1.08% 0.56% 0.74% 0.88% 1.83%
Long-Term Debt to Total Capital		 8.91% 10.08% 21.48% 25.27% 22.36% 15.48% 24.09% 26.15% 12.74% 12.29% 9.58%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 89.75% 86.74% 74.77% 71.42% 71.90% 83.63% 74.84% 73.29% 86.52% 86.83% 88.58%
Debt to EBITDA		 0.79 1.03 2.83 2.84 -8.94 1.50 1.79 2.02 1.09 1.13 0.96
Net Debt to EBITDA		 0.24 0.58 2.58 2.69 -7.95 0.84 1.54 1.80 -0.31 0.09 0.24
Long-Term Debt to EBITDA		 0.69 0.78 2.41 2.51 -7.12 1.42 1.72 1.98 1.03 1.05 0.81
Debt to NOPAT		 1.38 2.13 7.54 4.98 -5.83 2.95 2.97 3.36 2.07 2.13 1.57
Net Debt to NOPAT		 0.42 1.19 6.88 4.72 -5.18 1.66 2.55 2.99 -0.59 0.18 0.39
Long-Term Debt to NOPAT		 1.20 1.62 6.41 4.40 -4.64 2.79 2.84 3.29 1.95 1.99 1.31
Altman Z-Score		 4.63 4.09 3.35 3.25 3.00 3.45 3.50 3.56 4.09 3.78 3.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.10 1.95 1.92 2.11 1.67 1.66 1.87 2.11 2.10 2.01 1.76
Quick Ratio		 1.06 1.06 0.95 0.77 0.66 0.86 0.94 1.00 1.15 1.12 1.00
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -32 -47 -185 138 162 97 -137 -61 386 30 53
Operating Cash Flow to CapEx		 432.17% 1,072.17% 354.47% 276.56% 2,850.05% 4,941.47% -1,815.65% -358.44% 4,344.21% 1,355.89% 1,325.99%
Free Cash Flow to Firm to Interest Expense		 -14.97 -14.71 -20.33 10.50 13.29 14.07 -20.96 -3.09 29.61 3.71 8.02
Operating Cash Flow to Interest Expense		 24.58 29.51 2.72 1.22 14.89 16.85 -19.06 -1.81 28.52 14.02 18.68
Operating Cash Flow Less CapEx to Interest Expense		 18.89 26.76 1.95 0.78 14.37 16.51 -20.11 -2.31 27.86 12.99 17.27
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.39 2.22 1.73 1.62 1.62 1.87 1.96 1.89 1.69 1.71 1.74
Accounts Receivable Turnover		 6.54 5.96 4.93 5.56 6.31 6.23 5.44 5.11 4.88 5.00 4.59
Inventory Turnover		 5.73 5.84 4.96 4.97 5.34 6.05 5.72 4.87 4.50 5.28 5.54
Fixed Asset Turnover		 71.55 65.50 48.84 0.00 0.00 0.00 0.00 0.00 0.00 94.04 97.72
Accounts Payable Turnover		 6.55 6.47 5.20 5.44 5.71 5.14 4.60 4.75 4.47 4.44 4.13
Days Sales Outstanding (DSO)		 55.78 61.21 74.01 65.68 57.88 58.63 67.13 71.44 74.73 73.04 79.50
Days Inventory Outstanding (DIO)		 63.70 62.46 73.59 73.46 68.40 60.29 63.80 75.02 81.03 69.09 65.85
Days Payable Outstanding (DPO)		 55.75 56.43 70.23 67.13 63.89 70.98 79.33 76.82 81.60 82.27 88.47
Cash Conversion Cycle (CCC)		 63.74 67.25 77.37 72.01 62.38 47.93 51.60 69.64 74.16 59.86 56.87
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 802 909 1,133 1,069 861 812 1,040 1,199 883 918 940
Invested Capital Turnover		 4.70 4.17 3.10 2.95 3.16 3.77 3.81 3.38 3.13 3.38 3.47
Increase / (Decrease) in Invested Capital		 96 107 224 -65 -208 -49 228 159 -316 35 22
Enterprise Value (EV)		 979 1,092 1,297 1,184 846 797 1,019 1,030 1,053 956 1,088
Market Capitalization		 952 1,020 1,031 837 611 716 786 736 1,095 945 1,059
Book Value per Share		 $30.18 $33.07 $33.88 $35.56 $26.76 $28.71 $31.96 $36.36 $37.41 $40.11 $44.81
Tangible Book Value per Share		 $24.57 $21.12 $16.87 $18.76 $13.51 $16.00 $20.12 $24.90 $27.53 $27.12 $29.59
Total Capital		 863 965 1,159 1,280 943 874 1,078 1,235 1,068 1,044 1,028
Total Debt		 88 128 292 366 265 143 271 330 144 137 117
Total Long-Term Debt		 77 97 249 323 211 135 260 323 136 128 99
Net Debt		 27 72 267 347 236 80 233 294 -41 11 29
Capital Expenditures (CapEx)		 12 8.85 7.00 5.80 6.39 2.36 6.85 9.98 8.56 8.29 9.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 594 599 670 800 509 432 683 841 558 571 579
Debt-free Net Working Capital (DFNWC)		 655 655 695 819 539 495 721 877 743 697 668
Net Working Capital (NWC)		 644 625 652 776 484 487 710 870 735 687 649
Net Nonoperating Expense (NNE)		 0.57 -9.04 5.65 16 147 38 2.55 8.43 -7.35 -6.97 -3.89
Net Nonoperating Obligations (NNO)		 27 72 267 154 182 80 233 294 -41 11 29
Total Depreciation and Amortization (D&A)		 17 25 35 34 36 34 30 29 28 31 24
Debt-free, Cash-free Net Working Capital to Revenue		 16.78% 16.80% 21.17% 24.60% 16.71% 13.71% 19.35% 22.20% 17.11% 18.76% 17.96%
Debt-free Net Working Capital to Revenue		 18.51% 18.37% 21.97% 25.20% 17.67% 15.70% 20.43% 23.16% 22.80% 22.91% 20.70%
Net Working Capital to Revenue		 18.19% 17.51% 20.60% 23.89% 15.90% 15.45% 20.10% 22.98% 22.56% 22.61% 20.11%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.40 $2.74 $1.30 $2.25 ($7.59) $0.42 $3.48 $3.57 $3.10 $3.05 $3.69
Adjusted Weighted Average Basic Shares Outstanding		 26.47M 25.32M 25.52M 25.64M 25.38M 25.42M 25.50M 25.14M 24.87M 23.44M 21.38M
Adjusted Diluted Earnings per Share		 $2.38 $2.71 $1.29 $2.24 ($7.59) $0.42 $3.45 $3.54 $3.06 $3.00 $3.64
Adjusted Weighted Average Diluted Shares Outstanding		 26.69M 25.52M 25.62M 25.73M 25.38M 25.52M 25.76M 25.36M 25.22M 23.84M 21.69M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.63M 25.43M 25.59M 25.24M 25.36M 25.50M 25.19M 24.84M 24.03M 21.88M 20.14M
Normalized Net Operating Profit after Tax (NOPAT)		 65 64 60 92 44 56 91 98 73 70 77
Normalized NOPAT Margin		 1.84% 1.79% 1.88% 2.83% 1.45% 1.78% 2.59% 2.59% 2.24% 2.31% 2.39%
Pre Tax Income Margin		 2.71% 2.84% 1.99% 2.57% -2.36% 1.83% 3.36% 3.22% 3.06% 3.10% 3.22%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 44.58 30.91 7.51 7.22 -5.35 8.86 18.52 6.78 7.94 11.38 14.88
NOPAT to Interest Expense		 30.22 18.73 4.25 5.58 -3.72 7.00 14.00 4.97 5.35 8.06 11.37
EBIT Less CapEx to Interest Expense		 38.89 28.16 6.74 6.78 -5.87 8.52 17.47 6.28 7.29 10.34 13.47
NOPAT Less CapEx to Interest Expense		 24.54 15.97 3.49 5.14 -4.24 6.66 12.95 4.46 4.69 7.03 9.96
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 157.51% 30.16% 0.00% 16.46% -3.15% 0.00% 20.50% 17.43% 55.66% 148.88% 124.12%

Quarterly Metrics And Ratios for ScanSource

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 21,480,385.00 20,324,529.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 21,480,385.00 20,324,529.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.79 1.26
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -12.50% -15.01% -21.23% -11.49% -15.52% -6.34% 8.95% -4.63% 2.54% 8.79% 17.25%
EBITDA Growth		 4.88% -41.25% -17.21% -2.41% -44.05% 27.63% 18.86% 6.83% -10.79% -6.82% 10.57%
EBIT Growth		 5.25% -48.99% -20.20% -4.25% -54.01% 34.22% 23.47% 14.80% -5.18% -1.37% 18.43%
NOPAT Growth		 -21.81% -48.54% -21.98% -32.86% -27.21% 28.45% 26.17% 46.35% -4.91% 0.98% 24.85%
Net Income Growth		 27.17% -39.65% -14.44% 9.99% -47.89% 36.12% 24.81% 17.11% -3.28% -3.13% 27.51%
EPS Growth		 27.72% -39.76% -13.16% 13.11% -45.74% 48.00% 31.82% 28.99% 7.14% 5.41% 40.23%
Operating Cash Flow Growth		 335.15% 192.04% 458.69% -52.07% -109.79% -58.75% -86.03% -48.22% 598.40% 8.01% -129.72%
Free Cash Flow Firm Growth		 156.24% 227.53% 337.89% 1,720.44% 30.56% -77.91% -104.61% -92.62% -99.55% -86.33% 115.25%
Invested Capital Growth		 -8.61% -19.23% -26.37% -17.78% -13.48% -3.83% 3.95% 0.37% 1.55% 1.02% 2.41%
Revenue Q/Q Growth		 0.97% -14.94% -0.86% 3.95% -3.62% -5.71% 15.33% -9.01% 3.63% 0.04% 24.30%
EBITDA Q/Q Growth		 58.34% -50.37% 17.59% 5.61% -9.22% 13.20% 9.51% -5.08% -24.19% 18.24% 29.95%
EBIT Q/Q Growth		 76.38% -58.09% 24.25% 4.26% -15.28% 22.30% 14.30% -3.06% -30.03% 27.22% 37.24%
NOPAT Q/Q Growth		 12.94% -42.92% 23.96% -15.98% 22.45% 0.72% 21.76% -2.54% -20.44% 6.96% 50.54%
Net Income Q/Q Growth		 112.07% -60.87% 25.69% 5.45% 0.47% 2.22% 15.25% -1.06% -17.03% 2.38% 51.71%
EPS Q/Q Growth		 111.48% -61.24% 32.00% 4.55% 1.45% 5.71% 17.57% 2.30% -15.73% 4.00% 56.41%
Operating Cash Flow Q/Q Growth		 -32.40% 153.31% -65.82% -18.10% -113.80% 1,167.58% -88.43% 203.61% 32.87% 131.35% -103.18%
Free Cash Flow Firm Q/Q Growth		 958.05% 89.78% 41.62% -35.98% -24.12% -67.89% -129.57% 202.48% -95.38% 876.71% -67.02%
Invested Capital Q/Q Growth		 -3.88% -13.59% -5.16% 4.37% 1.16% -3.95% 2.51% 0.77% 2.35% -4.45% 3.92%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 11.39% 12.55% 13.04% 13.10% 13.61% 14.22% 12.93% 14.53% 13.43% 13.97% 12.57%
EBITDA Margin		 5.50% 3.21% 3.80% 3.87% 3.64% 4.37% 4.15% 4.33% 3.17% 3.74% 3.91%
Operating Margin		 3.03% 2.33% 2.93% 2.27% 2.47% 3.17% 3.30% 3.50% 2.33% 3.02% 3.33%
EBIT Margin		 4.67% 2.30% 2.88% 2.89% 2.54% 3.29% 3.27% 3.48% 2.35% 2.99% 3.30%
Profit (Net Income) Margin		 3.70% 1.70% 2.16% 2.19% 2.28% 2.47% 2.47% 2.69% 2.15% 2.20% 2.69%
Tax Burden Percent		 81.72% 71.33% 70.92% 73.92% 86.52% 71.95% 73.06% 73.63% 84.92% 70.20% 76.99%
Interest Burden Percent		 97.00% 103.76% 105.58% 102.45% 103.81% 104.33% 103.60% 104.92% 107.87% 105.01% 105.85%
Effective Tax Rate		 18.28% 28.67% 29.08% 26.08% 13.48% 28.05% 26.94% 26.37% 15.08% 29.80% 23.01%
Return on Invested Capital (ROIC)		 7.89% 5.52% 6.51% 5.20% 6.42% 7.43% 8.13% 8.39% 6.37% 7.26% 8.90%
ROIC Less NNEP Spread (ROIC-NNEP)		 12.80% 5.75% 6.97% 9.03% 7.83% -6.36% 4.68% 22.65% 10.31% -8.30% 14.78%
Return on Net Nonoperating Assets (RNNOA)		 3.10% 0.82% 0.96% 1.01% 0.66% 0.07% -0.08% 0.14% 0.38% 0.04% 0.33%
Return on Equity (ROE)		 11.00% 6.35% 7.47% 6.21% 7.08% 7.50% 8.05% 8.53% 6.75% 7.30% 9.23%
Cash Return on Invested Capital (CROIC)		 16.66% 28.41% 37.07% 25.75% 20.12% 10.54% 3.30% 7.29% 5.91% 6.78% 5.69%
Operating Return on Assets (OROA)		 8.57% 4.23% 4.88% 4.95% 4.41% 5.59% 5.57% 5.97% 4.12% 5.22% 5.72%
Return on Assets (ROA)		 6.80% 3.13% 3.66% 3.75% 3.96% 4.19% 4.22% 4.61% 3.78% 3.85% 4.66%
Return on Common Equity (ROCE)		 11.00% 6.35% 7.47% 6.21% 7.08% 7.50% 8.05% 8.53% 6.75% 7.30% 9.23%
Return on Equity Simple (ROE_SIMPLE)		 9.25% 8.45% 0.00% 8.54% 6.99% 7.49% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 22 13 16 13 16 16 20 19 15 16 24
NOPAT Margin		 2.48% 1.66% 2.08% 1.68% 2.13% 2.28% 2.41% 2.58% 1.98% 2.12% 2.56%
Net Nonoperating Expense Percent (NNEP)		 -4.91% -0.22% -0.46% -3.83% -1.41% 13.79% 3.45% -14.26% -3.93% 15.56% -5.87%
Return On Investment Capital (ROIC_SIMPLE)		 1.95% - - - 1.53% 1.54% 1.87% 1.82% 1.47% 1.58% 2.38%
Cost of Revenue to Revenue		 88.61% 87.45% 86.96% 86.90% 86.39% 85.78% 87.07% 85.47% 86.57% 86.03% 87.43%
SG&A Expenses to Revenue		 7.56% 8.85% 9.18% 9.25% 9.89% 9.89% 8.81% 10.18% 10.19% 10.18% 8.57%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 8.35% 10.22% 10.11% 10.83% 11.14% 11.05% 9.63% 11.03% 11.09% 10.96% 9.24%
Earnings before Interest and Taxes (EBIT)		 41 17 21 22 19 23 27 26 18 23 31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 49 24 28 30 27 31 34 32 24 29 37
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.04 1.17 1.18 1.25 0.00 0.88 1.04 1.05 0.94 0.86 1.16
Price to Tangible Book Value (P/TBV)		 1.41 1.60 1.61 1.89 0.00 1.32 1.54 1.54 1.44 1.32 1.76
Price to Revenue (P/Rev)		 0.28 0.32 0.34 0.37 0.00 0.27 0.31 0.32 0.28 0.25 0.33
Price to Earnings (P/E)		 11.21 13.90 14.21 14.68 0.00 11.81 13.20 12.93 11.60 10.63 13.42
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 8.92% 7.20% 7.04% 6.81% 0.00% 8.47% 7.57% 7.73% 8.62% 9.41% 7.45%
Enterprise Value to Invested Capital (EV/IC)		 1.03 1.18 1.19 1.25 0.00 0.88 1.04 1.05 0.94 0.86 1.16
Enterprise Value to Revenue (EV/Rev)		 0.31 0.32 0.32 0.37 0.00 0.27 0.31 0.32 0.30 0.25 0.34
Enterprise Value to EBITDA (EV/EBITDA)		 7.19 7.95 7.99 8.80 0.00 6.80 7.85 7.86 7.39 6.55 8.89
Enterprise Value to EBIT (EV/EBIT)		 8.86 10.06 10.18 11.27 0.00 9.19 10.49 10.30 9.55 8.35 11.09
Enterprise Value to NOPAT (EV/NOPAT)		 12.88 14.75 15.11 18.16 0.00 13.07 14.80 13.77 12.76 11.09 14.51
Enterprise Value to Operating Cash Flow (EV/OCF)		 5.67 3.63 2.83 3.58 0.00 4.96 8.51 10.73 6.99 5.85 8.83
Enterprise Value to Free Cash Flow (EV/FCFF)		 5.92 3.70 2.73 4.39 0.00 8.23 32.18 14.46 16.09 12.76 20.57
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.18 0.15 0.16 0.16 0.16 0.16 0.15 0.15 0.13 0.13 0.13
Long-Term Debt to Equity		 0.17 0.15 0.15 0.15 0.15 0.14 0.14 0.14 0.11 0.11 0.11
Financial Leverage		 0.24 0.14 0.14 0.11 0.08 -0.01 -0.02 0.01 0.04 0.00 0.02
Leverage Ratio		 2.15 2.06 2.10 2.01 1.88 1.90 1.95 1.91 1.90 1.95 2.05
Compound Leverage Factor		 2.09 2.14 2.22 2.06 1.95 1.98 2.02 2.00 2.05 2.05 2.17
Debt to Total Capital		 15.03% 13.38% 13.48% 13.65% 13.61% 13.42% 13.17% 12.93% 11.56% 11.56% 11.42%
Short-Term Debt to Total Capital		 0.70% 0.72% 0.74% 1.09% 0.95% 0.92% 0.88% 0.92% 1.88% 1.88% 1.83%
Long-Term Debt to Total Capital		 14.33% 12.66% 12.74% 12.56% 12.66% 12.50% 12.29% 12.01% 9.69% 9.68% 9.58%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 84.97% 86.62% 86.52% 86.35% 86.39% 86.58% 86.83% 87.07% 88.44% 88.44% 88.58%
Debt to EBITDA		 1.09 1.06 1.09 1.11 1.29 1.20 1.13 1.10 0.99 1.00 0.96
Net Debt to EBITDA		 0.80 -0.10 -0.31 0.00 0.29 -0.06 0.09 0.09 0.29 -0.02 0.24
Long-Term Debt to EBITDA		 1.04 1.00 1.03 1.02 1.20 1.12 1.05 1.02 0.83 0.84 0.81
Debt to NOPAT		 1.95 1.96 2.07 2.29 2.49 2.31 2.13 1.92 1.70 1.69 1.57
Net Debt to NOPAT		 1.43 -0.18 -0.59 0.01 0.55 -0.11 0.18 0.15 0.51 -0.03 0.39
Long-Term Debt to NOPAT		 1.86 1.86 1.95 2.11 2.32 2.15 1.99 1.78 1.43 1.41 1.31
Altman Z-Score		 4.12 4.07 3.93 3.88 0.00 3.65 3.66 3.84 3.66 3.48 3.49
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.30 2.20 2.10 2.03 2.11 2.07 2.01 2.16 1.96 1.86 1.76
Quick Ratio		 1.16 1.16 1.15 1.07 1.08 1.12 1.12 1.13 1.04 1.02 1.00
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 123 234 332 212 161 52 -15 16 0.72 7.07 2.33
Operating Cash Flow to CapEx		 2,479.37% 6,617.81% 4,310.16% 1,887.58% -313.63% 4,648.98% 303.73% 969.14% 1,561.57% 2,974.20% -90.27%
Free Cash Flow to Firm to Interest Expense		 36.74 117.04 159.00 100.68 81.79 28.18 -7.29 8.19 0.37 5.43 1.63
Operating Cash Flow to Interest Expense		 18.82 80.04 26.24 21.26 -3.14 35.98 3.64 12.13 15.85 54.76 -1.59
Operating Cash Flow Less CapEx to Interest Expense		 18.06 78.83 25.63 20.13 -4.14 35.21 2.44 10.88 14.83 52.92 -3.35
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.84 1.84 1.69 1.71 1.74 1.70 1.71 1.72 1.76 1.75 1.74
Accounts Receivable Turnover		 4.98 5.43 4.88 5.02 4.99 5.16 5.00 5.35 5.24 5.18 4.59
Inventory Turnover		 4.74 4.76 4.50 4.77 4.92 5.12 5.28 5.13 5.31 5.53 5.54
Fixed Asset Turnover		 0.00 96.03 0.00 0.00 0.00 90.68 94.04 92.23 97.06 96.78 97.72
Accounts Payable Turnover		 4.91 5.03 4.47 4.62 4.95 4.69 4.44 4.67 4.75 4.49 4.13
Days Sales Outstanding (DSO)		 73.25 67.20 74.73 72.72 73.19 70.73 73.04 68.28 69.68 70.45 79.50
Days Inventory Outstanding (DIO)		 77.07 76.69 81.03 76.58 74.14 71.30 69.09 71.12 68.73 65.98 65.85
Days Payable Outstanding (DPO)		 74.32 72.54 81.60 78.96 73.72 77.77 82.27 78.08 76.76 81.37 88.47
Cash Conversion Cycle (CCC)		 76.00 71.36 74.16 70.34 73.61 64.27 59.86 61.32 61.64 55.06 56.87
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,077 931 883 921 932 895 918 925 947 904 940
Invested Capital Turnover		 3.19 3.32 3.13 3.09 3.01 3.26 3.38 3.26 3.22 3.43 3.47
Increase / (Decrease) in Invested Capital		 -101 -222 -316 -199 -145 -36 35 3.40 14 9.16 22
Enterprise Value (EV)		 1,113 1,095 1,053 1,155 0.00 791 956 973 893 778 1,088
Market Capitalization		 989 1,109 1,095 1,154 0.00 798 945 963 857 780 1,059
Book Value per Share		 $38.19 $37.51 $37.41 $38.32 $37.83 $38.43 $40.11 $41.77 $41.51 $42.19 $44.81
Tangible Book Value per Share		 $28.04 $27.61 $27.53 $25.39 $25.21 $25.79 $27.12 $28.53 $27.08 $27.60 $29.59
Total Capital		 1,122 1,090 1,068 1,066 1,043 1,042 1,044 1,050 1,030 1,025 1,028
Total Debt		 169 146 144 146 142 140 137 136 119 118 117
Total Long-Term Debt		 161 138 136 134 132 130 128 126 100 99 99
Net Debt		 124 -13 -41 0.52 31 -6.53 11 11 36 -1.88 29
Capital Expenditures (CapEx)		 2.55 2.42 1.27 2.38 1.97 1.42 2.52 2.40 1.98 2.40 2.52
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 757 622 558 553 574 542 571 586 575 534 579
Debt-free Net Working Capital (DFNWC)		 802 781 743 698 684 688 697 711 658 654 668
Net Working Capital (NWC)		 795 773 735 686 674 678 687 701 639 635 649
Net Nonoperating Expense (NNE)		 -11 -0.29 -0.58 -3.94 -1.10 -1.36 -0.52 -0.80 -1.32 -0.65 -1.18
Net Nonoperating Obligations (NNO)		 124 -13 -41 0.52 31 -6.53 11 11 36 -1.88 29
Total Depreciation and Amortization (D&A)		 7.36 6.84 6.89 7.57 8.23 7.59 7.20 6.30 6.28 5.80 5.87
Debt-free, Cash-free Net Working Capital to Revenue		 21.08% 17.97% 17.11% 17.50% 18.98% 18.22% 18.76% 19.50% 19.00% 17.30% 17.96%
Debt-free Net Working Capital to Revenue		 22.33% 22.57% 22.80% 22.10% 22.64% 23.13% 22.91% 23.66% 21.77% 21.20% 20.70%
Net Working Capital to Revenue		 22.11% 22.34% 22.56% 21.73% 22.31% 22.81% 22.61% 23.33% 21.13% 20.58% 20.11%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.31 $0.51 $0.66 $0.70 $0.72 $0.75 $0.88 $0.90 $0.75 $0.79 $1.25
Adjusted Weighted Average Basic Shares Outstanding		 25.04M 25.03M 24.87M 24.15M 23.81M 23.28M 23.44M 22.02M 21.87M 21.31M 21.38M
Adjusted Diluted Earnings per Share		 $1.29 $0.50 $0.66 $0.69 $0.70 $0.74 $0.87 $0.89 $0.75 $0.78 $1.22
Adjusted Weighted Average Diluted Shares Outstanding		 25.33M 25.44M 25.22M 24.65M 24.22M 23.60M 23.84M 22.41M 22.11M 21.58M 21.69M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.17M 24.71M 24.03M 0.00 23.46M 22.60M 21.88M 21.94M 21.48M 20.32M 20.14M
Normalized Net Operating Profit after Tax (NOPAT)		 22 15 16 17 17 17 20 19 16 17 25
Normalized NOPAT Margin		 2.48% 2.03% 2.08% 2.16% 2.30% 2.37% 2.41% 2.61% 2.11% 2.16% 2.63%
Pre Tax Income Margin		 4.53% 2.39% 3.04% 2.96% 2.64% 3.44% 3.38% 3.65% 2.53% 3.14% 3.49%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 12.29 8.65 10.31 10.63 9.64 12.65 12.65 13.44 9.25 17.58 21.98
NOPAT to Interest Expense		 6.53 6.25 7.44 6.18 8.10 8.75 9.33 9.97 7.80 12.46 17.09
EBIT Less CapEx to Interest Expense		 11.53 7.44 9.70 9.50 8.64 11.87 11.45 12.19 8.24 15.74 20.22
NOPAT Less CapEx to Interest Expense		 5.77 5.04 6.83 5.05 7.10 7.98 8.13 8.71 6.78 10.62 15.33
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 19.17% 32.72% 55.66% 90.36% 149.35% 152.45% 148.88% 133.89% 125.68% 131.77% 124.12%

Financials Breakdown Chart

Key Financial Trends

ScanSource’s Q4 2026 results show a strong acceleration in revenue and earnings. Revenue increased to $953.1 million from $766.8 million in Q3, while net income rose to $25.6 million from $16.9 million. Diluted EPS improved to $1.22 from $0.78. Across the four reported 2026 quarters, revenue totaled approximately $3.23 billion, up about 3.3% from the comparable 2025 period, while net income increased roughly 10%.

Profitability was mixed but improved sequentially. Q4 gross profit rose to $119.8 million, although gross margin declined to approximately 12.6% from 14.0% in Q3 because cost of revenue grew faster than sales. Operating income nevertheless improved to $31.7 million, and the operating margin increased to about 3.3% from 3.0%. The latest quarter also included $1.8 million of restructuring charges, partially offset by $890,000 of other special income.

Cash generation remains the main concern. ScanSource produced $71.4 million and $30.8 million of operating cash flow in Q3 and Q2, respectively, but used $2.3 million in Q4. A $37.9 million use of operating working capital more than offset net income and noncash expenses. The company also repurchased $26.5 million of stock during Q4 and ended the latest reported balance-sheet period with $120.3 million of cash, $118.4 million of total debt and $906.3 million of equity. The balance sheet appears reasonably capitalized, but the business remains heavily dependent on managing receivables, inventory and supplier payables.

  • Q4 revenue growth accelerated: Revenue increased approximately 24% sequentially to $953.1 million, reversing the modest revenue levels recorded during the first three quarters of fiscal 2026.
  • Earnings momentum improved: Q4 net income increased approximately 52% sequentially, while diluted EPS advanced from $0.78 to $1.22.
  • Operating leverage emerged: Operating income rose to $31.7 million despite higher restructuring costs, suggesting that the larger revenue base helped absorb operating expenses.
  • Full-year earnings were higher: Based on the reported quarterly figures, fiscal 2026 net income was approximately $78.9 million, compared with about $71.5 million in fiscal 2025.
  • Share repurchases supported per-share results: ScanSource repurchased $26.5 million of common stock in Q4 and reduced weighted-average basic shares to 21.4 million from 23.4 million in Q4 2025.
  • Debt levels have improved over the broader period: Total debt reported at March 31, 2026, was approximately $118.4 million, down from roughly $135.7 million at September 30, 2025, and substantially below the debt levels reported in 2023.
  • Liquidity remains adequate but working-capital intensive: Cash totaled $120.3 million and current assets were approximately $1.37 billion versus current liabilities of $736.8 million, but most current assets consisted of receivables, inventory and prepaid expenses rather than cash.
  • Acquisition-related assets remain significant: Goodwill and intangible assets totaled approximately $309 million at March 31, 2026. These assets can support future earnings, but could require impairment charges if acquired businesses underperform.
  • Q4 operating cash flow turned negative: ScanSource used $2.3 million of cash in operations despite reporting $25.6 million of net income, primarily because of a $37.9 million working-capital outflow.
  • Gross-margin pressure persists: Q4 gross margin was approximately 12.6%, below Q3’s 14.0% and below the roughly 14.5% margin reported in Q4 2025, leaving the company sensitive to product mix and competitive pricing.
09/07/26 09:39 AM ETAI Generated. May Contain Errors.

ScanSource Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ScanSource's fiscal year ends in June. Their fiscal year 2026 ended on June 30, 2026.

ScanSource's net income appears to be on an upward trend, with a most recent value of $78.87 million in 2026, rising from $63.62 million in 2016. The previous period was $71.55 million in 2025. Check out ScanSource's forecast to explore projected trends and price targets.

ScanSource's total operating income in 2026 was $98.63 million, based on the following breakdown:
  • Total Gross Profit: $437.36 million
  • Total Operating Expenses: $338.73 million

Over the last 10 years, ScanSource's total revenue changed from $3.54 billion in 2016 to $3.23 billion in 2026, a change of -8.9%.

ScanSource's total liabilities were at $1.02 billion at the end of 2026, a 16.2% increase from 2025, and a 42.5% increase since 2016.

In the past 10 years, ScanSource's cash and equivalents has ranged from $19.31 million in 2019 to $185.46 million in 2024, and is currently $88.37 million as of their latest financial filing in 2026.

Over the last 10 years, ScanSource's book value per share changed from 30.18 in 2016 to 44.81 in 2026, a change of 48.5%.


Related Companies

Financial statements for NASDAQ:SCSC last updated on 8/20/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel